- Report
- March 2024
- 194 Pages
Global
From €3263EUR$3,374USD£2,763GBP
€3625EUR$3,749USD£3,070GBP
- Report
- March 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,095GBP
- Report
- April 2024
- 193 Pages
Global
From €5270EUR$5,450USD£4,464GBP
- Report
- November 2023
- 140 Pages
Global
From €2417EUR$2,499USD£2,047GBP
- Report
- October 2023
- 190 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- October 2023
- 181 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- November 2023
- 168 Pages
Global
From €2418EUR$2,500USD£2,047GBP
- Report
- February 2024
- 135 Pages
Global
From €4594EUR$4,750USD£3,890GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1934EUR$2,000USD£1,638GBP
- Report
- January 2024
- 125 Pages
Global
From €5754EUR$5,950USD£4,873GBP
- Report
- June 2023
- 150 Pages
Global
From €5754EUR$5,950USD£4,873GBP
- Report
- January 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,095GBP
- Report
- April 2024
- 898 Pages
Global
From €5415EUR$5,600USD£4,586GBP
- Report
- April 2024
- 578 Pages
Global
From €5270EUR$5,450USD£4,464GBP
- Report
- June 2023
- 100 Pages
Global
From €5754EUR$5,950USD£4,873GBP
- Report
- January 2024
- 149 Pages
Global
From €3771EUR$3,899USD£3,193GBP
- Report
- February 2024
- 115 Pages
Global
From €4594EUR$4,750USD£3,890GBP
- Report
- June 2023
- 165 Pages
Global
From €2418EUR$2,500USD£2,047GBP
- Report
- October 2023
- 145 Pages
Global
From €3046EUR$3,150USD£2,580GBP
- Report
- August 2023
- 180 Pages
United States
From €1924EUR$1,990USD£1,630GBP
The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists.
Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more